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In our subjective every-day
experience, it is apparent that odor
memories are fundamentally different
from other memories; however, the
phenomenon has proved to be
notoriously difficult to study under
controlled laboratory conditions.
Yeshurun et al.’s [3] approach of
combining associative memory
tests with functional magnetic
resonance imaging allowed them
to study how odor memories are
different at the neuronal level.
The identification of brain regions
implicated in the formation of
first-learned associations between
odors and objects opens the door for
research that will explicate the role of
olfactory processing, emotion, and
long-term memory in this intriguing
phenomenon.
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R989Phagocytosis: Invitation to a Feast
How does a macrophage find an apoptotic cell for ingestion? A recent study
shows that ATP and UTP released from the dying cell serve as important
chemoattractants for macrophages and are key contributors to the efficient
clearance of apoptotic cells in vivo.
Peter M. Henson
The deletion of excess, previously
used, unwanted or damaged cells is
essential in metazoa for development,
metamorphoses, tissue homeostasis,
responses to injury and for the
development and regulation of innate
and adaptive immunity. It is achieved
by the induction of various forms of
programmed cell death (PCD), of which
apoptosis is the best known. Critical
to the overall process, however, is the
subsequent recognition and removal
of the dying cell in a manner that can
distinguish between PCD and cell
death induced by external agents,
toxins, physical damage or,
particularly, infectious agents. For the
former, a quiet efficient removal is the
norm whereas, for the latter, the animal
needs to (and does) mount a protective
response that can encompass
engagement of the various innate and
adaptive immune processes with
which it is endowed. In mammals, this
is represented by the commonly noted
but also overly simplified distinction
between the non-inflammatory
and non-immunogenic response
to apoptotic cells versus the pro-
inflammatory and pro-immunogenic
effects of cells dying by non-PCD
(often loosely described as necrotic)
pathways.
Dying cells are removed by uptake
into phagocytic cells. In simpler
invertebrates, such as nematodes, this
is largely achieved by recognition by,
and uptake into, neighboring tissue
cells, and in fact this near-neighbor
removal can also occur in mammals,
as exemplified by post-lactation
remodeling of the mammary gland or,
for that matter, the constant daily
removal of retinal outer rod segments,
each achieved by epithelial cells. But
in animals with more professional and
mobile phagocytes, these have taken
on the major role in recognition,
phagocytosis and digestion of the
cells undergoing PCD. Many studies
have addressed these processes and
shown them to involve unique
mechanisms of uptake (often involving
ingestion of intact cells that can be
as large as 20mm in diameter),
unique sets of receptors and bridge
molecules (opsonins), and unique
intracellular signaling pathways, with
remarkable evolutionary conservation
of the entire process [1–3]. However,
the important question of how the
mobile phagocyte finds (is attracted
to) the cells undergoing PCD has
received much less attention. This
is the subject addressed in the
recent paper by Elliot et al. [4]
which reports identification of the
nucleotides ATP and UTP as primecandidates for what have been
colloquially called ‘find me’ signals,
following the various use of ‘eat me’
and ‘don’t eat me’ for apoptotic
cell uptake or inhibitory signals,
respectively.
The approach taken by Elliot et al. [4]
was to show release of chemotactic
factors for macrophages from
apoptotic cells in vitro, confirm with
macrophage attraction into skin
pouches in mice, identify candidate
molecules released from the apoptotic
cells and finger the likely receptors on
macrophages that were responsible.
To complete the story, they showed
that removal of the factors or blockade
of the candidate receptors reduced
clearance of apoptotic cells in an
in vivo model cell removal system
following massive lymphocyte
apoptosis in the thymus, which was
first described by Scott et al. [5]. Their
extensive series of experiments led to
the identification of ATP and UTP as
responsible molecules for apoptotic
cell attraction of macrophages. These
nucleotides are released from a
variety of cells undergoing apoptosis
in a caspase-dependent fashion,
apparently before the cells undergo
loss of plasmamembrane permeability.
They induce macrophage chemotaxis
in vitro and in vivo, and apoptotic
cell supernate induction of the
macrophage attraction was shown to
be abrogated by introduction of
apyrase to hydrolyze the nucleotides.
Overexpression of CD39 — a
mammalian ecto-enzyme involved in
natural nucleotide inactivation — was
shown to have a similar blocking
effect.
Current Biology Vol 19 No 21
R990Important studies by Inoue and
colleagues [6,7] had previously
implicated nucleotides in the regulation
of dead cell clearance by the microglial
cells of the brain. These, like peripheral
macrophages, are members of the
mononuclear phagocyte system,
arise from the same myeloid
precursors and serve as the
endogenous macrophages of the
central nervous system. But these
investigators suggested a possible
distinction between ATP (and ADP)
as microglial attractants and UDP as
an enhancer of the subsequent
phagocytic step. By contrast, Elliot
et al. [4] showed equal effects of both
ATP and UTP in their attraction
studies in vitro and in the periphery
(skin), and a markedly weaker effect
of ADP. Differences in purinergic
receptor usage between the two sets
of studies were also noted and may
suggest differences in receptor
expression between peripheral
macrophages and microglia or merely
technical differences between the
different systems — certainly
a candidate for future investigation.
Elliot et al. [4] showed that ATP
and UTP are both involved in the
macrophage migratory response to
apoptotic cells, and both appear to
act through the P2Y2 receptor, as
shown by the effect of blocking or
knocking down this receptor, and the
ineffectiveness of apoptotic cell
supernates to induce macrophage
attraction in P2Y2 knockout mice.
An important validating result was
the demonstration that apyrase
administration or the use of the
P2Y2
2/2 mice resulted in blockade
of the normally rapid clearance
of thymocytes following their
glucocorticoid-induced apoptosis.
These experiments were used by the
authors to suggest that the nucleotide
attractants they describe are essential
for macrophage attraction (Figure 1).
While this might be the case in this
particular system, it must be noted that
other ‘find me’ signals have been
suggested. In normal resolution
of the corpus luteum, macrophages
accumulate and are responsible for
clearance of the dying luteal cells.
Here, induction of the monocyte/
macrophage chemoattractant
chemokine (CCL12, MCP-1) from
remaining viable cells apparently
responding to the neighboring
apoptotic cells seemed to mediate
the attraction [8,9]. This may be
a mechanism that applies in other
situations in vivo. Another chemokine
candidate that has been invoked is
CX3CL1 (fractalkine): a deficiency of
its receptor (CX3CR1) was shown





















Figure 1. Finding apoptotic cells for clearance.
As cells become apoptotic (here represented by neutrophils), they release ATP and UTP which
attract macrophages within the tissues, and/or monocytes migrating from the blood, to ingest
and remove the dying cells. Nucleotidases on nearby cells, or even on the apoptotic cells or
macrophages themselves, would be expected to regulate this effect by destroying the
chemoattractants.macrophages to lymphoid follicle
germinal centers, presumably to the
apoptotic cells at that site [10]. Interest
here may extend to the important role
played by this molecule in selective
accumulation of monocyte subsets
from the blood (for example, [11,12]).
At issue may be which cell types can
release this chemokine as they
undergo apoptosis.
Lauber et al. [13] identified
lysophosphatidylcholine as
a completely different macrophage
attractant that was released from
apoptotic cells in vitro. Elliot et al. [4]
went to some lengths to address this
interesting candidate and could find
no evidence for its involvement, either
in vitro or in vivo. A potential
explanation for this difference may be
the status of the apoptosing cell, as
the Lauber studies required prolonged
incubation after initiating the apoptosis
and their results may be more
indicative of the post-apoptotic
(secondary) necrosis stage of cell
death that results in vivo if the dying
cells are not removed. Apoptotic cells
have, however, been shown to expose
lysophosphatidylcholine on their
surface, which, in some circumstances,
may participate in autoimmunity [14].
Again, the timepoint at which this
exposure/expression occurs may be
a key issue. A general point in
considering the various processes
involved in apoptotic (PCD) cell
removal is the considerable
redundancy that appears to be
involved in, for example, receptor
usage for their recognition, signal
pathways for uptake, and perhaps
now, attractant molecules to get the
macrophages to the site of cell death.
It is attractive to attribute such
redundancy to the ‘importance’ of
the processes, as well as to their
likely selective control in different
sites and situations.
This raises the question of which cell
is in fact attracted to sites at which cells
are undergoing PCD? For the most
part, mononuclear phagocytes arise
from precursors in the bone marrow,
enter the circulation as monocytes
which then penetrate the tissues, and
mature into tissue macrophages and
myeloid dendritic cells (as well as the
more tissue-specific variants, such as
Kupfer cells, osteoclasts, microglia,
and so on). Cells undergoing apoptosis
might, therefore, either attract resident
tissue macrophages or dendritic cells
from within the tissue, and/or new
Dispatch
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would then be expected to mature
within the tissue to gain the phagocytic
potential to ingest the apoptotic cells.
(Blood monocytes appear to be
inefficient in this regard, in part,
perhaps, because they need to develop
an appropriate size and membrane
pool, not to mention the appropriate
receptors and signaling capability,
to ingest whole apoptotic cells or
apoptotic bodies.) The in vivo studies
by Elliot et al. [4] (or the other studies
indentified above) do not distinguish
between these possibilities, although
the microglial systems are less likely
to involve emigration from the blood
since this would require breach of
the blood-brain barrier. Accordingly,
they might represent a system for
focusing on the attraction of resident
‘macrophages’ to local sites
of cell death.
There is substantial current interest
in roles played in tissues by emigration
of monocyte subsets, especially those
exhibiting differential expression of
CX3CR. Following the demonstration
by Elliot et al. [4] of a role for P2Y2, one
might reasonably question the extent
of its expression on monocytes and
monocyte subsets as well as on the
very widely variable subsets of
macrophages seen in vivo. We know
already that different macrophage
populations showwide variability in the
apoptotic cell recognition receptors
that they express, so a comparable
complexity may apply to possible
different attractant receptors, with the
presumption that this contributes
greater degrees of control over the
processes at different sites and in
different circumstances. One must
also raise the question of attraction
of dendritic cells to sites of cell death;
the cells migrating into the skin
pouches shown by Elliot et al. [4] might
have included dendritic cells, with
relevant implications for their complex
roles in immunologic regulation.
Thus, many fascinating questions
remain. For example, how are the
nucleotides, generally thought to be
membrane impermeable, released
from the apoptosing cells? Why are
they not rapidly destroyed by
ecto-nucleotidases as was shown in
the overexpression of CD39. If such
enzymes are lost on the actual dying
cell, they would still be expected to be
present on nearby viable cells. Some
cells, such as platelets, release ATP
when activated and a series offascinating studies has shown that
neutrophils emigrating through
epithelia can themselves, or perhaps
with attached platelets, also release
ATP [15,16]. Might such emigration,
especially if it applied to emigration
through endothelia as well, also
contribute to the monocyte/
macrophage accumulation that
occurs in neutrophilic inflammation
(although many other monocyte
chemoattractants have already been
implicated in this).
In this regard, a remaining concern
with the work of Elliot et al. [4] using the
air-pouch model is whether an earlier
accumulation of neutrophils, which
themselves can generate a number
of monocyte chemoattractants,
contributed to the attraction of
monocytes/macrophages that was
assessed at 24 hours. What in fact
is the effect of the nucleotides on
other inflammatory cells such as
neutrophils? They too express P2Y
receptors (as noted in the commentary
by Gregory [17]). Then one could
consider the potential effects of the
nucleotide release from necrotic cells?
Again this could have just as valid
implications for attraction of
macrophages to mediate the clearance
of cell debris, though in this case the
consequence would presumably be
pro-inflammatory rather than the
silent, inflammosuppressive and
immunosuppressive outcome seen
with cells undergoing programmed
cell death. What are the other
consequences for the monocytes or
macrophages of ATP/UTP stimulation
through P2Y2 or other purinergic
receptors. A possible enhancement
of the subsequent cell uptake has
already been noted above and Elliot
et al. [4] themselves raised the
question of a contribution to the
inflammosuppression. If it is primarily
the monocyte that is attracted, might
there be a role for the local nucleotides
in their maturation, and if so, to result in
what specific macrophage phenotypic
properties?
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